UBS Group’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $189K | Sell |
139,244
-358,613
| -72% | -$488K | ﹤0.01% | 5518 |
|
|
2025
Q1 | $483K | Buy |
497,857
+263,039
| +112% | +$255K | ﹤0.01% | 4699 |
|
|
2024
Q4 | $301K | Buy |
234,818
+232,168
| +8,761% | +$297K | ﹤0.01% | 5021 |
|
|
2024
Q3 | $5.25K | Buy |
2,650
+150
| +6% | +$297 | ﹤0.01% | 6866 |
|
|
2024
Q2 | $5.05K | Sell |
2,500
-281
| -10% | -$568 | ﹤0.01% | 6870 |
|
|
2024
Q1 | $5.03K | Sell |
2,781
-2,930
| -51% | -$5.3K | ﹤0.01% | 6394 |
|
|
2023
Q4 | $4.82K | Buy |
5,711
+3,151
| +123% | +$2.66K | ﹤0.01% | 6613 |
|
|
2023
Q3 | $2.29K | Buy |
2,560
+60
| +2% | +$54 | ﹤0.01% | 6585 |
|
|
2023
Q2 | $2.23K | Sell |
2,500
-18,046
| -88% | -$16.1K | ﹤0.01% | 6704 |
|
|
2023
Q1 | $10K | Buy |
20,546
+9,535
| +87% | +$4.64K | ﹤0.01% | 6522 |
|
|
2022
Q4 | $5.62K | Buy |
11,011
+9,011
| +451% | +$4.6K | ﹤0.01% | 7957 |
|
|
2022
Q3 | $2K | Sell |
2,000
-3,511
| -64% | -$3.51K | ﹤0.01% | 8596 |
|
|
2022
Q2 | $7K | Sell |
5,511
-3,295
| -37% | -$4.19K | ﹤0.01% | 7424 |
|
|
2022
Q1 | $13K | Buy |
8,806
+3,439
| +64% | +$5.08K | ﹤0.01% | 6986 |
|
|
2021
Q4 | $10K | Buy |
+5,367
| New | +$10K | ﹤0.01% | 7645 |
|